[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":146,"states":147},"Infection",22,15,[8,16,22,28,34,40,46,52,58,64,70,76,82,88,94,100,108,114,121,127,133,139],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06954129","A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients",[12],"Phase 4","RECRUITING","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:28.835536Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06384651","Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty",[12],"2026-08-26T02:17:54.420226Z","2026-05-05T02:35:31.675987Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07556107","The Vancomycin Piperacillin\u002FTazobactam (VPT) Patient Safety Trial (VPS)",[12],"2026-08-26T02:19:29.119921Z","2026-05-13T02:55:06.721869Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06145724","EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)",[],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:27.656607Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT07110636","Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients",[],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:29.523953Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT06637904","TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections",[],"2026-08-26T02:17:27.435233Z","2026-05-05T02:43:29.135989Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT02545478","Biomarkers in Infection",[],"2026-08-26T02:15:36.077529Z","2026-05-13T02:55:06.101854Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT02435810","Inflammatory and Infectious Diseases of the Nervous System",[],"2026-08-26T02:17:43.321968Z","2026-05-13T02:55:06.094681Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":62,"content_modified":63},"NCT02299921","Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure",[],"2026-08-26T02:16:49.565137Z","2026-05-13T02:55:06.093448Z",{"nct_id":65,"title":66,"phases":67,"status":13,"updated_at":68,"content_modified":69},"NCT00557726","Diagnosis and Management of Inflammatory and Infectious Diseases",[],"2026-08-26T02:18:41.390601Z","2026-05-13T02:55:06.037701Z",{"nct_id":71,"title":72,"phases":73,"status":13,"updated_at":74,"content_modified":75},"NCT01904188","Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?",[],"2026-08-26T02:18:58.141497Z","2026-07-05T05:32:16.768771Z",{"nct_id":77,"title":78,"phases":79,"status":13,"updated_at":80,"content_modified":81},"NCT07128095","COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise",[],"2026-08-26T02:18:32.765187Z","2026-05-13T02:55:06.657528Z",{"nct_id":83,"title":84,"phases":85,"status":13,"updated_at":86,"content_modified":87},"NCT05603728","Exactech Shoulder Post Market Clinical Follow-up Study",[],"2026-08-26T02:18:15.214990Z","2026-05-13T02:55:06.366104Z",{"nct_id":89,"title":90,"phases":91,"status":13,"updated_at":92,"content_modified":93},"NCT06623318","IV Ensure in Patients Receiving OPAT",[],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:27.337362Z",{"nct_id":95,"title":96,"phases":97,"status":13,"updated_at":98,"content_modified":99},"NCT06224933","Augmented Reality For MRI-Guided Interventions",[],"2026-08-26T02:18:42.501841Z","2026-05-05T02:43:27.303648Z",{"nct_id":101,"title":102,"phases":103,"status":105,"updated_at":106,"content_modified":107},"NCT07602166","Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans",[104],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:18:46.137046Z","2026-05-29T15:36:40.221533Z",{"nct_id":109,"title":110,"phases":111,"status":105,"updated_at":112,"content_modified":113},"NCT05943938","Comparison of Sepsis Prediction Algorithms",[],"2026-08-26T02:15:15.642947Z","2026-05-13T02:55:06.394698Z",{"nct_id":115,"title":116,"phases":117,"status":118,"updated_at":119,"content_modified":120},"NCT06160349","EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3)",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:32.589113Z","2026-06-16T05:54:07.717571Z",{"nct_id":122,"title":123,"phases":124,"status":118,"updated_at":125,"content_modified":126},"NCT00001351","Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders",[],"2026-08-26T02:18:47.742071Z","2026-06-16T05:54:07.943564Z",{"nct_id":128,"title":129,"phases":130,"status":118,"updated_at":131,"content_modified":132},"NCT07296263","Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems",[],"2026-08-26T02:17:23.750999Z","2026-06-16T05:54:07.878879Z",{"nct_id":134,"title":135,"phases":136,"status":118,"updated_at":137,"content_modified":138},"NCT05443321","Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes",[],"2026-08-26T02:16:04.914942Z","2026-06-16T05:54:08.032266Z",{"nct_id":140,"title":141,"phases":142,"status":143,"updated_at":144,"content_modified":145},"NCT06002685","Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:34:16.012157Z","2026-05-05T02:43:29.219976Z",[],[148,152,156],{"state":149,"count":150,"slug":151},"New York",6,"new-york",{"state":153,"count":154,"slug":155},"Maryland",5,"maryland",{"state":157,"count":158,"slug":159},"Massachusetts",4,"massachusetts"]